Insider Transactions in Q4 2022 at Molina Healthcare, Inc. (MOH)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2022
|
Marc Russo EVP, Health Plans |
SELL
Open market or private sale
|
Direct |
1,500
-8.82%
|
$526,500
$351.17 P/Share
|
|
Dec 07
2022
|
Dale B Wolf Director |
SELL
Open market or private sale
|
Direct |
2,500
-3.64%
|
$850,000
$340.1 P/Share
|
|
Nov 29
2022
|
Joseph M Zubretsky President & CEO |
SELL
Bona fide gift
|
Direct |
4,600
-1.8%
|
-
|
|
Nov 07
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
150
-0.9%
|
$49,650
$331.56 P/Share
|
|
Nov 07
2022
|
Dale B Wolf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+25.01%
|
$198,000
$33.02 P/Share
|
|
Oct 31
2022
|
Richard M Schapiro Director |
SELL
Open market or private sale
|
Direct |
3,000
-10.12%
|
$1,065,000
$355.15 P/Share
|
|
Oct 07
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
28,914
-1.52%
|
$10,004,244
$346.14 P/Share
|
|
Oct 07
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,914
+9.24%
|
$1,937,238
$67.33 P/Share
|
|
Oct 06
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-2.19%
|
$10,620,000
$354.55 P/Share
|
|
Oct 06
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Oct 05
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.38%
|
$10,470,000
$349.18 P/Share
|
|
Oct 05
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Oct 04
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.37%
|
$10,260,000
$342.81 P/Share
|
|
Oct 04
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Oct 03
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.22%
|
$10,050,000
$335.41 P/Share
|
|
Oct 03
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Oct 01
2022
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+1.1%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+0.99%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+1.37%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+2.97%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+0.81%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+11.85%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-1.54%
|
$37,177
$329.84 P/Share
|
|
Oct 01
2022
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+3.38%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+3.85%
|
$54,943
$329.84 P/Share
|